- Development of novel adjuvants
- Construction of in vitro and in vivo infection experimental systems for each pathogen
- Establishment of specimen collection system from clinical cases
Research Content
Collection of clinical specimens from patients and subjects at Hokkaido University Hospital and related hospitals, which are clinical sites, infection of newly developed vaccine candidates in humans and mice In vitro and in vivo using comprehensive immune system analysis platform will be evaluated. In addition, we will promote the development of new therapeutic drugs, including peptide drugs, and conduct clinical trials of vaccines and therapeutic drugs developed through this research.
Division of Vaccinology for Clinical Development
-
Deputy Director/Head of Division of Vaccinology for Clinical DevelopmentNorihiro Sato, M.D., Ph.D.ProfessorHokkaido University Hospital
-
Satoshi Konno, M.D., Ph.D.ProfessorHokkaido University
Graduate School of Medicine -
Akihiko Sato, DVM., PhD.Visiting ProfessorHokkaido University (Shionogi & Co., Ltd.)
-
Kazuhiro Matsuo, Ph.D.Specially Appointed ProfessorHokkaido University
Institute for Vaccine Research and Development: IVReD -
Kensuke Takada, DVM., PhD.Specially Appointed Associate ProfessorHokkaido University
Institute for Vaccine Research and Development :IVReD -
Satoru Mizuno, Ph.D.Specially Appointed Associate ProfessorHokkaido University
Institute for Vaccine Research and Development: IVReD
-
Hiroto Takeuchi, PhD.Specially Appointed Assistant ProfessorHokkaido University
Institute for Vaccine Research and Development:IVReD
-
Kiyoshi Takayama, PhD.Visiting ProfessorHokkaido University
(NB Health Laboratory Co. Ltd.)